Begin main content

Rapid Genome-wide Testing: Clinical Utility and Cost-Effectiveness

Last updated: August 21, 2019
Project Number: RB1390-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical utility of providing rapid turnaround for genome-wide testing for patients in intensive care?
  2. What is the cost-effectiveness of providing rapid turnaround for genome-wide testing for patients in intensive care?
  3. What are the evidence-based guidelines of providing rapid turnaround for genome-wide testing for patients in intensive care?

Key Message

​One randomized controlled trial and three non-randomized studies were identified regarding the clinical utility of providing rapid turnaround for genome-wide testing for patients in intensive care. No relevant economic evaluations or evidence-based guidelines were identified